InsidersTradesSigma
Follow the CYNATA THERAPEUTICS LIMITED share price and the full insider trade history of the company, a listed issuer based in Australia. Shares trade on the AU market, under the oversight of ASX. Market capitalisation: €2.7m. The latest transaction was reported on 2 July 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Cynata Therapeutics Limited es una empresa biofarmacéutica australiana centrada en el desarrollo de terapias celulares. Utiliza su plataforma de producción de células madre para abordar diversas enfermedades.